What is the catalog number for Apolipoprotein A I/APOA1 Rabbit Polyclonal Antibody?

The catalog number for Apolipoprotein A I/APOA1 Rabbit Polyclonal Antibody is orb334578.

What sizes are available for Apolipoprotein A I/APOA1 Rabbit Polyclonal Antibody?

Apolipoprotein A I/APOA1 Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Apolipoprotein A I/APOA1 Rabbit Polyclonal Antibody

Q: Is Apolipoprotein A I/APOA1 Rabbit Polyclonal Antibody in stock?

Apolipoprotein A I/APOA1 Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Product Specifications

Product Name Alternative

Apolipoprotein A-I; Apo-AI; ApoA-I; Apolipoprotein A1; Proapolipoprotein A-I; ProapoA-I; Apoa1

UniProt

P04639

Reactivity

Rat

Cross Reactivity

No cross-reactivity with other proteins.

Immunogen

E. coli-derived rat APOA1 recombinant protein (Position: D25-A259) . Rat APOA1 shares 61.7% and 68.6% amino acid (aa) sequence identity with human and mouse APOA1, respectively.

Target

Apolipoprotein A-I

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Cardiovascular Research, Metabolism Research, Signal Transduction

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Immunohistochemistry (Paraffin-embedded Section), 0.5-1μg/ml, Rat Western blot, 0.1-0.5μg/ml, Rat

Form

Lyophilized

Molecular Weight

24 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

IHC, WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.